EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dimerization as a key feature of autoreactive IgA antibody responses

Anouk G van Mourik, Jim B D Keijser, Myrthe A M van Delft, Sanne Reijm, Alice Bacon, Theo Rispens, Nivine E W Levarht, Rayman T N Tjokrodirijo, Peter A van Veelen, Leendert A Trouw, René E M Toes, Karin A van Schie und 3 weitere

Annals of the Rheumatic Diseases · 2026-05 · 85 (5) · 797-805

DOI: 10.1016/j.ard.2025.11.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026-05. Verfasst von Anouk G van Mourik und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Immunoglobulin A, Autoantibodies, Rheumatic Diseases, Autoimmune Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council, Netherlands Organisation for Health Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The presence of immunoglobulin A (IgA) autoantibodies has been described in many autoimmune diseases, and some of its characteristics, such as IgA dimerization, are considered a sign of a mucosal origin. However, limited information is available about the (patho)physiological conditions leading to the development of monomeric vs dimeric (autoreactive) IgA in humans. Therefore, we investigated IgA dimerization in rheumatic autoimmune diseases with a possible mucosal origin, as well as after vaccination. METHODS: Plasma of patients with rheumatic disease (rheumatoid arthritis [RA], systemic sclerosis [SSc], anti-neutrophil cytoplasmic antibody associated vasculitis [AAV], systemic lupus erythematosus [SLE]), SARS-CoV-2 vaccinated healthy individuals, and healthy controls was used for size exclusion chromatography (SEC). Enzyme-linked immunosorbent assays were performed on SEC fractions to determine the size of IgA. Results were confirmed using western blot and tandem mass spectrometry. RESULTS: The proportion of dimeric IgA was increased for autoantibodies compared to total IgA. This was most evident in RA, AAV, and SLE (dimeric autoreactive IgA ≈ 60%-80% vs total IgA ≈ 20%, SLE ≈ 60% total IgA), but not in SSc. Intramuscular vaccination against SARS-CoV-2 also led to an increased proportion of dimeric anti-spike IgA shortly after vaccination, irrespective of previous mucosal exposure. CONCLUSIONS: These findings indicate that dimeric (autoreactive) IgA responses are associated with newly emerging antigen-specific immune activation, where production temporarily shifts to dimeric IgA. Mucosal triggering is not necessarily always involved in these IgA immune responses. These findings provide key insights into the circumstances for IgA dimerization and suggest that dimeric IgA could serve as a marker for immunological disease activity in autoimmunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin AAutoantibodiesRheumatic DiseasesAutoimmune DiseasesHumansSARS-CoV-2FemaleMaleCOVID-19Middle AgedAdultCOVID-19 VaccinesCase-Control StudiesAgedProtein MultimerizationLupus Erythematosus, Systemic

Substanzen

Immunoglobulin AAutoantibodiesCOVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Sanquin Research Amsterdam, Amsterdam, The Netherlands; Department of Molecular Cell Biology and Immunology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Amsterdam Institute for Immun…
  • Department of Molecular Cell Biology and Immunology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Amsterdam Institute for Immunology and Infectious Diseases, Immunology, Amsterdam, Th…
  • Department of Immunology, MS Center ErasMS, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.

Förderung

  • Dutch Research Council
  • Netherlands Organisation for Health Research and Development

Zitieren

APA

van Mourik, A. G., Keijser, J. B. D., van Delft, M. A. M., Reijm, S., Bacon, A., Rispens, T., Levarht, N. E. W., Tjokrodirijo, R. T. N., van Veelen, P. A., Trouw, L. A., Toes, R. E. M., van Schie, K. A., Oskam, N., van der Woude, D., & T2B! immunity against SARS-CoV-2 study group (2026). Dimerization as a key feature of autoreactive IgA antibody responses. Annals of the Rheumatic Diseases, 85(5), 797-805. https://doi.org/10.1016/j.ard.2025.11.003

Vancouver

van Mourik AG, Keijser JBD, van Delft MAM, Reijm S, Bacon A, Rispens T, et al. Dimerization as a key feature of autoreactive IgA antibody responses. Annals of the Rheumatic Diseases. 2026;85(5):797-805. doi:10.1016/j.ard.2025.11.003

BibTeX
@article{vanMourik2026,
  author = {van Mourik, Anouk G and Keijser, Jim B D and van Delft, Myrthe A M and Reijm, Sanne and Bacon, Alice and Rispens, Theo and Levarht, Nivine E W and Tjokrodirijo, Rayman T N and van Veelen, Peter A and Trouw, Leendert A and Toes, René E M and van Schie, Karin A and Oskam, Nienke and van der Woude, Diane and T2B! immunity against SARS-CoV-2 study group, T2B! immunity against SARS-CoV-2 study group},
  title = {Dimerization as a key feature of autoreactive IgA antibody responses},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {5},
  pages = {797--805},
  doi = {10.1016/j.ard.2025.11.003}
}
Kostenlos starten →